8-K: Venus Concept Secures $2 Million in Convertible Notes from EW Healthcare Partners

Venus Concept has obtained $2 million in secured convertible notes from EW Healthcare Partners to bolster its financial position and support strategic objectives.

Summary

• Venus Concept has entered into a Note Purchase and Registration Rights Agreement with EW Healthcare Partners, securing $2 million in convertible notes.
• The notes accrue interest at SOFR plus 8.5% annually, payable in kind quarterly, with a maturity date of December 9, 2025.
• Holders can convert the notes into common stock at an initial conversion price of approximately $1.251 per share.
• A maximum of 1,598,721 shares of common stock may be issued upon conversion at the initial rate.
• The company has the option to redeem the notes at par plus accrued interest and a premium, subject to certain conditions.
• The notes are secured by a Guaranty and Security Agreement, granting a security interest in substantially all of the company's assets.
• The notes are subordinated to the company's existing secured debt with City National Bank of Florida.
• The company is required to file a registration statement for the resale of shares issued upon conversion by March 18, 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company secured funding, it also acknowledges weaker-than-expected revenue and the need for a strategic turnaround. The reliance on convertible notes and the subordination to existing debt suggest some financial challenges.

Positives

• The financing provides Venus Concept with additional liquidity to support ongoing operations.
• The company has reduced its cash used in operations by approximately 50% year-over-year in 2023.
• The convertible notes offer a flexible financing option with potential for equity conversion.

Negatives

• The company's fourth quarter 2023 revenue results were softer-than-expected.
• The notes are subordinated to existing secured debt, potentially impacting recovery in case of default.
• The company is subject to various covenants that limit its ability to engage in specified transactions.

Risks

• The company's ability to operate its business could be significantly affected if the investors foreclose on the collateral.
• The company is subject to restrictions on incurring additional debt or liens without investor consent.
• The company's common stock could be delisted from the Nasdaq Capital Market if it fails to meet listing requirements.
• The company's ability to repay the notes is dependent on its future financial performance.

Future Outlook

The company expects this financing to provide additional liquidity to support ongoing operations and execution of its near-to-intermediate term strategic turnaround objectives.

Management Comments

• Rajiv De Silva, Chief Executive Officer of Venus Concept, thanked EW Healthcare for their partnership and support.
• He noted that while Q4 2023 revenue was softer than expected, the company reduced its cash used in operations by approximately 50% year-over-year.

Industry Context

This announcement reflects a trend of medical aesthetic companies seeking financing to support growth and operations, particularly in a challenging economic environment. The use of convertible notes is a common strategy for companies seeking capital while providing investors with potential upside through equity conversion.

Comparison to Industry Standards

• The interest rate of SOFR plus 8.5% is within the typical range for convertible notes issued by companies in the medical device and aesthetics industry.
• The conversion price of $1.251 per share is a premium to the current trading price of the stock, which is common in convertible note offerings.
• The subordination of the notes to existing secured debt is a standard practice in such financings.
• The inclusion of a mandatory redemption provision upon receipt of employee retention credits is a unique feature specific to this company's circumstances.

Related Party Transactions

• The convertible notes were issued to EW Healthcare Partners, L.P. and one of its affiliates, indicating a related-party transaction.

Stakeholder Impact

• Shareholders may experience dilution if the notes are converted into common stock.
• Employees may benefit from the company's improved financial stability.
• Customers may see continued product development and support.
• Creditors may be impacted by the subordination of the new debt.

Next Steps

• The company will file a registration statement for the resale of shares issued upon conversion.
• The company will use the proceeds to satisfy the Minimum Deposit Relationship and for working capital and other general corporate purposes.
• The company will continue to execute its strategic turnaround objectives.

Key Dates

Keywords

convertible notes, secured debt, financing, EW Healthcare Partners, subordination, registration rights, liquidity, medical aesthetics, Venus Concept, SOFR